Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |